Park, J.-W., Barrette, A.-M., Wang, W., Grossauer, S., Grant, G., Lau, K., … Petritsch, C. (2021). BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS. In Neuro-Oncology (Vol. 23, pp. i3–i4). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noab090.012

Park, Jong-Whi, Anne-Marie Barrette, Wei Wang, Stefan Grossauer, Gerald Grant, Ken Lau, Sharon Pitteri, Michelle Monje, and Claudia Petritsch. “BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS.” In Neuro-Oncology, 23:i3–4. Oxford University Press (OUP), 2021. https://doi.org/10.1093/neuonc/noab090.012.

Park J-W, Barrette A-M, Wang W, Grossauer S, Grant G, Lau K, et al. BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS. In: Neuro-Oncology. Oxford University Press (OUP); 2021. p. i3–4.

Park, Jong-Whi, et al. “BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS.” Neuro-Oncology, vol. 23, no. Supplement_1, Oxford University Press (OUP), 2021, pp. i3–4. Crossref, doi:10.1093/neuonc/noab090.012.

Park J-W, Barrette A-M, Wang W, Grossauer S, Grant G, Lau K, Pitteri S, Monje M, Petritsch C. BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS. Neuro-Oncology. Oxford University Press (OUP); 2021. p. i3–i4.